UK markets open in 6 hours 39 minutes
NIKKEI 225
38,088.91 -316.75 (-0.82%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.34 -0.59 (-0.72%) GOLD FUTURES
2,303.10 +0.20 (+0.01%) DOW
37,815.92 -570.17 (-1.49%) Bitcoin GBP
48,455.33 -2,613.02 (-5.12%)
Taysha Gene Therapies, Inc. (TSHA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 2.4500 |
| Open | 2.5400 |
| Bid | 2.4200 x 500 |
| Ask | 2.4500 x 500 |
| Day's range | 2.4000 - 2.5400 |
| 52-week range | 0.5000 - 3.8900 |
| Volume | |
| Avg. volume | 2,826,846 |
| Market cap | 454.454M |
| Beta (5Y monthly) | 0.26 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.9600 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.35 |
Simply Wall St.Analysts' Revenue Estimates For Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Are Surging Higher
Shareholders in Taysha Gene Therapies, Inc. ( NASDAQ:TSHA ) may be thrilled to learn that the analysts have just...
GlobeNewswireTaysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DALLAS, April 05, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system (CNS), today announced that, on April 1, 2024, the Compensation Committee of Taysha's Board of Directors granted three new employees, in the aggregate, options to purchase 140,000 shares of the Company's common stock in connection
- Simply Wall St.
News Flash: Analysts Just Made A Notable Upgrade To Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Forecasts
Taysha Gene Therapies, Inc. ( NASDAQ:TSHA ) shareholders will have a reason to smile today, with the analysts making...
© 2024 Yahoo. All rights reserved.